News

WHO pauses trial of hydroxychloroquine in COVID-19 patients due to safety concerns

GENEVA, May 25 (Reuters) – The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghe…
Read More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close